Funded Projects › HORIZON
METAMIC 3 · Metaproteome-based leveraged microbiome management in the context of One Health
One Health is an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals, and environment ecosystems. All three domains are interconnected by microbiomes. Microbiomes are present universally and are connected by species exchange, impacting human and animal health but also environmental and biotechnological processes. Targeted control of the taxonomic and functional microbiome composition by microbial effectors such as antibiotics, antimicrobial peptides, and phages could be a game changer for these fields. However, the impact of microbial key factors on modulating microbiomes, the mechanisms implicated and the functional consequences, are barely understood. A novel approach which provides unique insights into the dynamics and the roles of microbial effectors is metaproteomics. The metaproteomics approach allows us to quantify the microbial composition and the expressed metabolic functions as well as to detect phages, antimicrobial resistance associated proteins, and non-ribosomal peptides. Leading European scientists of the Metaproteomics Initiative (https://metaproteomics.org/) formed a strategic alliance to set up a powerful and interdisciplinary network called METAMIC to capitalize on the potential of metaproteomics for developing novel strategies for microbiome control, manipulation/engineering, and restoration based on microbial effectors. METAMIC will achieve this by training a new generation of highly skilled microbiome and metaproteomics scientists, spreading their knowledge in research, industry, the medical sector, and public authorities. Developing novel metaproteomics workflows and exemplifying them in various clinical and biotechnological field studies will provides important steps towards better understanding and managing our microbiomes in the future, fitting the key EU missions, including “climate change”, “climate-neutral and smart cities”, “soil deal”, “restore ocean and water”, and “cancer”.
Consortium · 31 organisations
LEIBNIZ-INSTITUT FUR ANALYTISCHE WISSENSCHAFTEN-ISAS-EV
DE · €580,545
PHILIPPS UNIVERSITAET MARBURG
DE
THE UNIVERSITY OF SHEFFIELD
UK
FORSCHUNGSZENTRUM JULICH GMBH
DE
ROBERT KOCH-INSTITUT
DE
Centre de Ressources et Competences pour la Mucoviscidose de Montpellier-Occitanie
FR
UNIVERSITEIT GENT
BE · €288,540
UNIVERSITAT WIEN
AT
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
FR · €629,338
UNIVERSITE DE MONTPELLIER
FR
HELMHOLTZ-ZENTRUM FUR UMWELTFORSCHUNG GMBH - UFZ
DE · €290,272
PHYLOGENE
FR
UNIVERSITA DEGLI STUDI DI CAGLIARI
IT
UNIVERSITAET LEIPZIG
DE
AGRO INNOVATION INTERNATIONAL
FR
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
ES · €282,188
UNIVERSITA DI PISA
IT · €281,755
UNIVERSITE DU LUXEMBOURG
LU · €288,540
UNIVERSITA DEGLI STUDI DI SASSARI
IT · €281,755
UNIVERSITE DE LILLE
FR
MINISTERE DE LA SANTE ET DE LA SECURITE SOCIALE
LU
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
NL
Myria Biosciences AG
CH
UNIVERSIDAD AUTONOMA DE MADRID
ES
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
DE · €290,272
HOCHSCHULE ANHALT
DE · €290,272
UNIVERSITAET BIELEFELD
DE
UNIVERSITAET HOHENHEIM
DE · €290,272
TECHNISCHE UNIVERSITEIT DELFT
NL · €610,572
Microviable Therapeutics, S.L.
ES
FAGOTERAPIA LAB S.R.L.
IT
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.